Chloroprocaine Hci Injection, Solution
Product Images NDC 51662-1401

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Chloroprocaine Hci (NDC 51662-1401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51662 1401 1 Vial Label

51662 1401 1 Vial Label
Nesacaine is a medication administered by injection for infiltration and nerve block. It contains 0.6g of chloroprocaine HCI per 30mL vial with 20 nggppermL. It is not recommended for caudal, epidural or spinal anesthesia. The vial is a multiple dose vial with methylparaben and is only available with a prescription.*
FDA Label Image

51662 1401 2 Pouch Labeling

51662 1401 2 Pouch Labeling
NESACAINE (CHLOROPROCAINE HCL INJECTION) is a sterile and non-pyrogenic solution used for infiltration and nerve block only. It is not for caudal, epidural, or spinal anesthesia. The solution comes in a 30 mL vial with a strength of 2% (600 mg/30mL). Each mL contains Chloroprocaine HCl 20 mg, Sodium Chloride 4.7 mg, Disodium Edetate®.111mg, Methylparaben 1 mg, and sodium hydroxide/hydrochloric acid to adjust the pH to 2.7-4.0. The usual dosage depends on the condition and is mentioned in the insert. It should not be autoclaved or used if discolored. The solution should be protected from light and stored at 20-25°C (68-77°F). The manufacturer is HFAcquisitionCo., LLC, and the NDC is 51662-1481-2. The lot number is 123456, and the expiration date is 2030-081-81.*
FDA Label Image

51662 1401 3 Case Labeling

51662 1401 3 Case Labeling
NESACAINE® (CHLOROPROCAINE HC L INJECTION, USP) is a medication that comes in a 30mL vial with a 2% concentration of Chloroprocaine HC l (600mg/30mL). The vial has a box of 25 doses. It is for infiltration and nerve block use only, and should not be used for caudal, epidural, or spinal anesthesia. The medicine is sterile and non-pyrogenic and contains Chloroprocaine HCL, Sodium chloride, Methylparaben, and Disodium EDTA dihydrate. The pH level of the solution is adjusted to between 2.7 to 4.0 with Sodium Hydroxide and/or Hydrochloric Acid. It should not be discarded If the solution is discolored. The usual dosage is mentioned in the insert. The medicine should be protected from light and stored between 20°C and 25°C (68°F to 77°F). The controlled room temperature of the medicine is provided by the USP. The Manufacturer is HFAcquisitionCo., LLC, and the original NDC code is 63323-476-37.*
FDA Label Image

51662 1401 3 Rfid Labeling

FDA Label Image

Description (Description 1)

Description (Description 1)
This is a table that shows different products and their corresponding formula in milligrams per milliliter. The products are identified by their components such as Chloro-procaine, Sodium Chloride, Disodium EDTA, and Methylparaben. The table provides information for four Nesacaine products and their respective formula for different percentages.*
FDA Label Image

Dosage (Dosage)

Dosage (Dosage)
This is a table displaying different anesthesia procedures, along with the corresponding volumes and doses of solutions used. The procedures include mandibular, infraorbital, brachial plexus, digital, pudendal, and paracervical. The table provides information on the total volume and dose of the solutions used for each procedure.*
FDA Label Image

How Supplied 1 (How Supplied 1)

How Supplied 1 (How Supplied 1)
This is a product description of two different units of a medication available for sale with different strengths, 1% and 2%. The 1% unit is sold under the product code 470537 and has a strength of 300mg per 30mL with a 10mg per mL dose in a vial of 25 units. The 2% unit is sold under the product code 470637 and has a strength of 600mg per 30mL with a 20mg per mL dose in a vial of 25 units.*
FDA Label Image

How Supplied 2 (How Supplied 2)

How Supplied 2 (How Supplied 2)
This text describes two products with different strengths and unit of sale. The first product has a strength of 2%, a unit of sale of 25 vials per box, and each vial contains 20mg per mL, with a total volume of 20mL. The second product has a strength of 3%, a unit of sale of 25 vials per box, and each vial contains 30mg per mL, with a total volume of 20mL. The products are identified by their respective codes and NDC numbers.*
FDA Label Image
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
This is a list of examples of different classes of drugs, including nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs such as acetaminophen, metoclopramide, quinine, and sulfasalazine.*
FDA Label Image

Serialized Labeling (Serialized Labeling)

Serialized Labeling (Serialized Labeling)
This is a description of a medicine called Nesacaine. The text includes identification numbers (01)00351662140116 and (17)200731, as well as an NDC number 63323-476-37. The medicine is delivered through injection and includes chloroprocalnesp HCI and methylparaben. It comes in a 30mL multiple dose vial.*
FDA Label Image

Structure (Structure)

FDA Label Image

Vial 1 (Vial 1)

FDA Label Image

Vial 2 (Vial 2)

FDA Label Image

Vial 3 (Vial 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.